From Data to Insights: Leveraging GenAI in Real-World Evidence (RWE) Studies

In healthcare, GenAI holds immense promise for revolutionizing medical research, diagnosis and treatment. But how can GenAI be utilized in the case of Real-World Evidence (RWE)? And to what extent can one leverage this technology effectively to enhance trial efficiency, improve data analysis capabilities and drive meaningful discoveries?

In our Climedo Connect on June 27, 2024, Dragan Mileski (Co-Founder and CTO of Climedo) will explore how to meaningfully apply GenAI across the field of clinical trials, with a specific focus on RWE. 

What to expect: 

• Understanding GenAI: Explore the fundamentals of GenAI, including emerging trends and technology outlook, to grasp its potential in transforming RWE studies.
• Top use cases for GenAI in post-market studies: Dive into the practical applications of GenAI in post-market studies, examining its role in drug safety monitoring, comparative effectiveness analysis and more.
• Best practices for incorporating GenAI in clinical research: Learn actionable strategies and best practices for seamlessly integrating GenAI into your trials. 

Don't miss this opportunity to gain valuable insights and contribute to the discussion on enhancing collaboration between trial physicians, sponsors, and CROs in clinical trials.